German American Bancorp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.21M | Sell |
28,574
-45
| -0.2% | -$9.98K | 0.53% | 43 |
|
|
2025
Q4 | $6.54M | Sell |
28,619
-210
| -0.7% | -$47.8K | 0.56% | 40 |
|
|
2025
Q3 | $6.68M | Buy |
28,829
+915
| +3% | +$186K | 0.59% | 40 |
|
|
2025
Q2 | $5.18M | Buy |
27,914
+231
| +0.8% | +$42.9K | 0.51% | 42 |
|
|
2025
Q1 | $5.8M | Sell |
27,683
-1
| -0% | -$194 | 0.62% | 39 |
|
|
2024
Q4 | $4.92M | Buy |
27,684
+302
| +1% | +$55.5K | 0.52% | 40 |
|
|
2024
Q3 | $5.41M | Buy |
27,382
+2,751
| +11% | +$513K | 0.57% | 41 |
|
|
2024
Q2 | $4.22M | Buy |
24,631
+617
| +3% | +$102K | 0.49% | 45 |
|
|
2024
Q1 | $4.37M | Buy |
24,014
+668
| +3% | +$115K | 0.53% | 43 |
|
|
2023
Q4 | $3.62M | Buy |
23,346
+242
| +1% | +$35.3K | 0.48% | 46 |
|
|
2023
Q3 | $3.44M | Buy |
23,104
+1,467
| +7% | +$215K | 0.5% | 46 |
|
|
2023
Q2 | $2.92M | Buy |
21,637
+259
| +1% | +$38K | 0.41% | 49 |
|
|
2023
Q1 | $3.41M | Sell |
21,378
-370
| -2% | -$56.6K | 0.51% | 47 |
|
|
2022
Q4 | $3.51M | Buy |
21,748
+105
| +0.5% | +$16.1K | 0.56% | 49 |
|
|
2022
Q3 | $2.9M | Sell |
21,643
-10
| -0% | -$1.44K | 0.5% | 47 |
|
|
2022
Q2 | $3.32M | Sell |
21,653
-767
| -3% | -$117K | 0.56% | 43 |
|
|
2022
Q1 | $3.63M | Sell |
22,420
-541
| -2% | -$78.6K | 0.53% | 45 |
|
|
2021
Q4 | $3.11M | Buy |
22,961
+361
| +2% | +$42.6K | 0.44% | 44 |
|
|
2021
Q3 | $2.44M | Buy |
22,600
+535
| +2% | +$61.1K | 0.38% | 46 |
|
|
2021
Q2 | $2.49M | Buy |
22,065
+1,128
| +5% | +$127K | 0.39% | 45 |
|
|
2021
Q1 | $2.27M | Buy |
20,937
+1,563
| +8% | +$167K | 0.39% | 46 |
|
|
2020
Q4 | $2.08M | Buy |
19,374
+440
| +2% | +$42.3K | 0.41% | 43 |
|
|
2020
Q3 | $1.66M | Sell |
18,934
-162
| -0.8% | -$15.3K | 0.41% | 44 |
|
|
2020
Q2 | $1.87M | Buy |
19,096
+834
| +5% | +$73.4K | 0.5% | 43 |
|
|
2020
Q1 | $1.39M | Buy |
18,262
+96
| +0.5% | +$8.18K | 0.41% | 46 |
|
|
2019
Q4 | $1.61M | Sell |
18,166
-11,179
| -38% | -$928K | 0.39% | 53 |
|
|
2019
Q3 | $2.22M | Buy |
29,345
+10,147
| +53% | +$696K | 0.59% | 44 |
|
|
2019
Q2 | $1.4M | Buy |
19,198
+732
| +4% | +$57.5K | 0.38% | 52 |
|
|
2019
Q1 | $1.49M | Buy |
18,466
+242
| +1% | +$19.8K | 0.44% | 50 |
|
|
2018
Q4 | $1.68M | Buy |
18,224
+536
| +3% | +$47.1K | 0.56% | 47 |
|
|
2018
Q3 | $1.67M | Sell |
17,688
-245
| -1% | -$23.2K | 0.5% | 50 |
|
|
2018
Q2 | $1.66M | Buy |
+17,933
| New | +$1.75M | 0.52% | 50 |
|
Other funds holding ABBV
VCM
VPM
German American Bancorp's ABBV Position: Q1 2026 in Review
German American Bancorp reduced its AbbVie (ABBV) stake by 0.16% in Q1 2026, selling an estimated $9.98K and leaving 28,574 shares worth $6.21M. The position accounts for 0.53% of the portfolio, ranked #43.
German American Bancorp first reported a position in ABBV in Q2 2018 and has held it in 32 quarters since. The position peaked at $6.68M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- German American Bancorp held 28,574 shares of AbbVie worth $6.21M as of Q1 2026.
- German American Bancorp sold 45 AbbVie shares in Q1 2026, an estimated $9.98K.
- AbbVie made up 0.53% of German American Bancorp's portfolio in Q1 2026, its #43 holding.
- German American Bancorp first reported a position in AbbVie in Q2 2018 and has held it in 32 quarters since.
- German American Bancorp's AbbVie position peaked at $6.68M in Q3 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on German American Bancorp's 13F filing for Q1 2026, filed 6 May 2026.